Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METHOXYFLURANE or VR Headset vs Standard Analgesia for Anterior Shoulder Dislocation
NCT05821517Phase 4Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methoxyflurane in anterior shoulder dislocation (3 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Decrease in the rate of procedural sedation of anterior shoulder dislocation at Day 1. Started Dec 2023; status: recruiting.
02
Drugs
methoxyflurane
03
Conditions
anterior shoulder dislocation
Beyond the preview
Go deeper on NCT05821517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05821517.